There was a 6- and 19.3-fold increased frequency of CD4+ and CD8+ SARS-CoV-2-specific T cells producing IFN-γ in PASC participants compared to RC participants (Fig 1B and 1C). The gene discussed is CD8A; the disease is long COVID-19.